Patent Application Filed for Probiotic Strain BMB18

Summary by 6ix AI

The company is collaborating with European research partners and has initiated a human clinical trial with La Trobe University, expected to begin in the fourth quarter of the fiscal year. This patent filing supports Biome's competitive positioning and provides a pathway for future commercialization of its innovations through its Activated Probiotics brand. The filing represents the first outcome of Biome's strategic initiative to develop next-generation probiotic solutions.

Written by 6ix AI from the company’s filing. How 6ix writes summaries